Suppression of ovarian function with the transdermally given synthetic progestin ST 1435 (Q67575998)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

title

Suppression of ovarian function with the transdermally given synthetic progestin ST 1435 (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

physiology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

hematologic tests

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

clinical research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

oral hormonal contraceptives

25 September 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

developed country

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

Northern Europe

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

progestins

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

Case control studies

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

author name string

M. Laurikka-Routti

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

M. Haukkamaa

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

P. Lähteenmäki

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1426309

25 September 2022

language of work or name

English

0 references

publication date

1 October 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

published in

Fertility and Sterility

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

volume

58

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

page(s)

680-684

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

Endometrial responses to transdermal estradiol in postmenopausal women

15 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Transdermal Testosterone Therapy in the Treatment of Male Hypogonadism*

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Transdermal administration of oestrogen/progestagen hormone replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Progesterone cream for cyclic breast pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Long-term Contraception with a single implant of the progestin ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Pituitary and ovarian function during contraception with one subcutaneous implant releasing a progestin, ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Contraception with subdermal implants releasing the progestin ST-1435: a dose-finding study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

A contraceptive vaginal ring releasing ethinyl estradiol and the progestin ST-1435: bleeding control, serum steroid concentrations, serum lipids and serum chemistry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Transdermal absorption of the progestin ST-1435: Therapeutic serum steroid concentrations and high excretion of the steroid in saliva

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Endometrial effect of transdermal estradiol and progestin ST-1435 in postmenopausal women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Concentration-dependent mechanisms of ovulation inhibition by the progestin ST-1435

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Norplant: subdermal implant system for long-term contraception

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Characteristics of ovarian follicular development in Norplant users.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

The significance of bleeding patterns in Norplant implant users

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Treatment with Norplant subdermal implants inhibits sperm penetration through cervical mucus in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

Innovative technology for hormonal replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2955311-4

10.1016/S0015-0282(16)55311-4

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1426309%20AND%20SRC:MED&resulttype=core&format=json

15 September 2019

1 reference